A Phase II Trial of Neoadjuvant Erlotinib (TARCEVA®) Followed by Surgery for Selected Patients with Stage IIIA, N2-Positive Non-Small Cell Lung Cancer

被引：0
|
作者：
Lim, Taekyu [1 ]
Baek, Kyung Kee [1 ]
Yi, Jun Ho [1 ]
Sin, Jong-Mu [1 ]
Lee, Jeeyun [1 ]
Park, Yeon Hee [1 ]
Ahn, Jin Seok [1 ]
Ahn, Myung-Ju [1 ]
Park, Keunchil [1 ]
机构：
[1] Samsun Med Ctr, Dept Hematol Oncol, Seoul, South Korea
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S394 / S394
页数：1
相关论文
共 50 条
  • [21] Phase II study of neoadjuvant chemotherapy with paclitaxel and cisplatin in Stage IIIA N2 non-small cell lung cancer.
    Choi, IS
    Oh, DY
    Kim, DW
    Kim, YT
    Kim, TY
    Yoo, CK
    Kim, YW
    Heo, DS
    Bang, YJ
    Kim, NK
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 692S - 692S
  • [22] Trimodality therapy for mediastnoscopic N2-positive non-small cell lung cancer
    Ahn, Y
    Kang, M
    Nam, H
    Oh, D
    Park, Y
    Lim, D
    Park, K
    Shim, Y
    Kwon, O
    LUNG CANCER, 2005, 49 : S165 - S165
  • [23] A randomized trial comparing induction chemotherapy followed by surgery with surgery alone for patients with stage IIIA N2 non-small cell lung cancer (JCOG 9209)
    Nagai, K
    Tsuchiya, R
    Mori, T
    Tada, H
    Ichinose, Y
    Koike, T
    Kato, H
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2003, 125 (02): : 254 - 260
  • [24] Randomized phase II trial of pemetrexed-cisplatin plus bevacizumab or thoracic radiotherapy followed by surgery for stage IIIA (N2) nonsquamous non-small cell lung cancer
    Takamochi, Kazuya
    Suzuki, Kenji
    Tsuboi, Masahiro
    Niho, Seiji
    Ishikura, Satoshi
    Oyamada, Shunsuke
    Yamaguchi, Takuhiro
    Okada, Morihito
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2022, 164 (03): : 661 - +
  • [25] Clinical outcomes of surgery after induction treatment in patients with pathologically proven N2-positive stage III non-small cell lung cancer
    Yang, Haitang
    Yao, Feng
    Zhao, Yang
    Zhao, Heng
    JOURNAL OF THORACIC DISEASE, 2015, 7 (09) : 1616 - 1623
  • [26] Neoadjuvant (induction) erlotinib response in stage IIIA non-small-cell lung cancer
    Kappers, Ingrid
    Klomp, Houke M.
    Burgers, Jacobus A.
    Van Zandwijk, Nico
    Haas, Rick L. M.
    van Pel, Renee
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (25) : 4205 - 4207
  • [27] A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients
    Tetsuo Tani
    Katsuhiko Naoki
    Hiroyuki Yasuda
    Daisuke Arai
    Kota Ishioka
    Keiko Ohgino
    Satoshi Yoda
    Sohei Nakayama
    Ryosuke Satomi
    Hideki Terai
    Shinnosuke Ikemura
    Takashi Sato
    Kenzo Soejima
    Cancer Chemotherapy and Pharmacology, 2019, 84 : 1065 - 1071
  • [28] A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients
    Tani, Tetsuo
    Naoki, Katsuhiko
    Yasuda, Hiroyuki
    Arai, Daisuke
    Ishioka, Kota
    Ohgino, Keiko
    Yoda, Satoshi
    Nakayama, Sohei
    Satomi, Ryosuke
    Terai, Hideki
    Ikemura, Shinnosuke
    Sato, Takashi
    Soejima, Kenzo
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (05) : 1065 - 1071
  • [29] Phase II pilot study of neoadjuvant docetaxel and cisplatin followed by adjuvant erlotinib in patients with stage I-III non-small cell lung cancer (NSCLC)
    Gold, K. A.
    Lee, J. J.
    Rice, D.
    Tse, W.
    Stewart, D.
    Wistuba, I.
    Herbst, R. S.
    Lippman, S. M.
    Hong, W. K.
    Kim, E. S.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [30] Chemotherapy and surgery in stage IIIa non-small cell lung cancer
    Skarin, Arthur T.
    JOURNAL OF THORACIC ONCOLOGY, 2007, 2 (06) : 577 - 578
12345